News

Non Standardized drug

Updated on : 04-04-2018

Non Standardized drug
The Ministry of Health and Sport, Food and Drug Administration Department investigated and discovered non-standardized drug in the market. It has been informed to the companies to withdraw them from the market at the relevant states and divisions. Therefore, in the future, that non-standardize drug distribution will not be allowed in the market and the investigation process will do on the distribution of them.


The Ministry of Health and Sport, Food and Drug Administration Department investigated and discovered non-standardized drug in the market. It has been informed to the companies to withdraw them from the market at the relevant states and divisions. Therefore, in the future, the following non-standardize drug distribution will not be allowed in the market and the investigation process will do on the distribution of them-

No.

Description

Name of Manufacturer

Batch No.

1

Flumyan 500 Capsule(Flucloxacillin Sodium BP eq. to Flucloxacilin 500mg)

India

FMD/ 6001

2

Flumyan 250 Capsule (Flucloxacillin Sodium BP eq.to Flucloxacillin 250 mg)

Maan Pharmaceuticals Ltd, India

FMT/ 6001

3.

Swifrucid 40 Tablet (Frusemide BP 40mg)

Swiss Pharma Pvt. Ltd, India

6273

4.

Pai Cotokin Tablet (Artemether 20mg, Lumefantrine 120 mg)

Ningbo Shuangwei Pharmaceutical Co., Ltd, PR China

0805

5.

Amnacloxa Capsule (Ampicillin Trihydrate BP eq.to Ampicillin 250mg, Cloxacillin Sodium BP eq.to Cloxacillin 250mg)

AMN Lifesciences Pvt. Ltd, India

6022

 



Most Recent News


Search All News

Displaying 11-20 of 894 result(s).
TitleCategoryDownload
General
General
General
General
General
General
General
General
General
General